You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(603259.SH)擬向特定對象增發不超6820.54萬股H股
格隆匯 03-24 22:12

格隆匯3月24日丨藥明康德(603259.SH)公佈,2020年3月24日,經公司第一屆董事會第三十九次會議暨2019年年度董事會會議,審議通過《關於公司增發H股股票方案的議案》。

為擴大H股投資者基礎、擴大全球產能及優化公司資本結構,公司擬提請公司2019年年度股東大會、2020年第一次A股類別股東會議及2020年第一次H股類別股東會議批准特別授權以新增發行H股。

公司將向特定對象增發不超過6820.54萬股H股,增發H股的募集資金在扣除發行相關費用後的淨額將用於以下用途:

1.約35%將用於併購項目,包括但不僅限於通過併購擴大公司及其子公司在美國、歐洲和亞太地區的業務;

2.約20%將用於拓展公司及其子公司的海外業務;

3.約15%將用於常熟藥明康德新藥生產和研發一體化項目(一期);

4.約10%將用於償還銀行貸款及其他借款;以及5.剩餘金額將用於補充一般運營資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account